Mark G. Currie, Chief Scientific Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 1,800 shares at $16.94 ($30K) on 2017-02-22, disclosed to the SEC on 2017-02-24.
Scheduled sale ($30k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IRWD | SELL | 2021-06-16 | $546K | — | Filing → |
| CYCN | SELL | 2020-12-30 | $121K | — | Filing → |
| IRWD | SELL | 2020-01-24 | $755K | — | Filing → |